Peng Jiang
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 11
- MicroRNA in disease regulation 6
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 17
- Pulmonary and Respiratory Medicine top 0.5%
- Cerebrovascular and Carotid Artery Diseases 8
- Ferroptosis and cancer prognosis 8
- Immunology top 1%
- Molecular Biology top 1%
- RNA modifications and cancer 7
-
- Intracranial Aneurysms: Treatment and Complications 13
- Vascular Malformations Diagnosis and Treatment 5
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Peng Jiang
85 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 2.5k
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 3.6k
- Immunology 2.1k
- Molecular Biology 4.4k
Countries citing papers authored by Peng Jiang
This map shows the geographic impact of Peng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Jiang more than expected).
Fields of papers citing papers by Peng Jiang
This network shows the impact of papers produced by Peng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Jiang. The network helps show where Peng Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 48 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 13 | |
| 10 | 2021 | 115 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 45 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 104 | |
| 15 | 2019 | 1 | |
| 16 | A major chromatin regulator determines resistance of tumor cells to T cell–mediated killingbreakdown → | 2018 | 567 |
| 17 | 2018 | 41 | |
| 18 | 2018 | 14 | |
| 19 | 2017 | 106 | |
| 20 | 2013 | 26 |
About Peng Jiang
Peng Jiang is a scholar working on Cancer Research, Neurology, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 92 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Intracranial Aneurysms: Treatment and Complications (13 papers), Cancer Genomics and Diagnostics (11 papers), Cerebrovascular and Carotid Artery Diseases (8 papers), Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (6 papers) and Vascular Malformations Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (3.3k citations), Pulmonary and Respiratory Medicine (3.6k citations), Immunology (2.1k citations) and Molecular Biology (4.4k citations). Peng Jiang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include X. Shirley Liu, Bo Li, Jingxin Fu, Myles Brown, Kai W. Wucherpfennig, Shengqing Gu, Xihao Hu, Ziyi Li, Deng Pan and Nicole Traugh. Their work appears in journals such as Genome biology, Nature Medicine, Nature Communications, Nucleic Acids Research and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.